Polish Patients' Needs and Opinions about the Implementation of Pharmaceutical Care in Diabetes

Int J Environ Res Public Health. 2023 Jan 4;20(2):945. doi: 10.3390/ijerph20020945.

Abstract

The study aimed to get to know patients' opinions on implementing pharmaceutical care for diabetic patients in a community pharmacy to prevent and effectively and holistically approach the treatment of people with diabetes. It was based on an authorial survey form and conducted from August to October 2021 in a community pharmacy in Poznan, Poland. A total of 131 pharmacy patients over 18 years were included in the study. Results showed that the vast majority of patients confirmed their interest in pharmaceutical care in diabetes conducted by pharmacists. Moreover, 79.4% of respondents would like to benefit from medicines use review, while 87.0% confirmed an interest in the 'New Drug' service, with diabetic patients being particularly interested in this (p = 0.2447). Most respondents were also interested in education on how to use a glucose meter, administer insulin and use a lancing device. In addition, the study showed patients' insufficient knowledge about risk factors and prevention of diabetes with the need for patient education. As the source of funding, 91.7% of diabetic patients indicated the National Health Fund. Given that such a service has not been implemented in Poland yet, this study may support established teams at the Supreme Pharmaceutical Chamber or the Ministry of Health in introducing such new services.

Keywords: community pharmacy; diabetes; patient education; pharmaceutical care; pharmacists; procedural instruction.

MeSH terms

  • Community Pharmacy Services*
  • Diabetes Mellitus* / drug therapy
  • Humans
  • Pharmacists
  • Poland
  • Risk Factors
  • Surveys and Questionnaires

Grants and funding

This research received no external funding. The APC was funded by Poznan University of Medical Sciences.